In vitro antifungal susceptibility profile of Iranian Fusarium isolates: Emphasizing on the potent inhibitory effect of efinaconazole compared to other drugs.
Mohsen NosratabadiLeila FaeliIman HaghaniRasoul MohammadiSadegh KhodavaisyReza KachueiFarzad KatiraeeSeyed Reza AghiliTahereh ShokohiMohammad Taghi HedayatiMehdi NazeriMohammad Javan-NikkhahHossein ZarrinfarJavad JavidniaMohammad-Javad NajafzadehMaryam SalimiAbdullah M S Al HatmiHamid BadaliMahdi AbastabarPublished in: Mycoses (2022)
Efinaconazole, a novel triazole, may be a promising candidate for the treatment of superficial Fusarium infections. Furthermore, the development of systemic formulations of these drugs as well as further in vitro and in vivo investigations could aid in the treatment of systemic fusariosis.